Laura Venditto, Daniela Dolce, Silvia Campana, Pamela Vitullo, Marco Di Maurizio, Cristina Fevola, Francesca Lucca, Giovanni Taccetti, Vito Terlizzi
{"title":"囊性纤维化和非囊性纤维化支气管扩张患者的诺卡氏菌分离:意大利多中心研究","authors":"Laura Venditto, Daniela Dolce, Silvia Campana, Pamela Vitullo, Marco Di Maurizio, Cristina Fevola, Francesca Lucca, Giovanni Taccetti, Vito Terlizzi","doi":"10.3390/antibiotics14030317","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b><i>Nocardia</i> species are an emergent pathogen in people with CF (pwCF) or bronchiectasis. Their clinical role and management remain unclear, and their isolation is a challenge. In this paper, we describe four cases of Nocardia detection, in two pwCF and two patients with non-CF bronchiectasis or primary ciliary dyskinesia (PCD). <b>Methods:</b> We conducted a multicenter retrospective study, involving pwCF and non-CF people with bronchiectasis who presented with a <i>Nocardia</i> detection and were followed at three CF Italian centers (Florence, Verona, and Cerignola). <b>Results:</b><i>Nocardia</i> detection was associated with clinical and radiological respiratory exacerbation and decline in lung function. In one CF patient, <i>Nocardia</i> was not detected in sputum cultures after starting Elexacaftor-Tezacaftor-Ivacaftor therapy. <b>Conclusions:</b> Managing <i>Nocardia</i> detection in patients with underlying lung diseases such as CF, PCD, or bronchiectasis presents significant challenges for clinicians.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"14 3","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11939271/pdf/","citationCount":"0","resultStr":"{\"title\":\"Nocardia Isolation in People with Cystic Fibrosis and Non-CF Bronchiectasis: A Multicenter Italian Study.\",\"authors\":\"Laura Venditto, Daniela Dolce, Silvia Campana, Pamela Vitullo, Marco Di Maurizio, Cristina Fevola, Francesca Lucca, Giovanni Taccetti, Vito Terlizzi\",\"doi\":\"10.3390/antibiotics14030317\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b><i>Nocardia</i> species are an emergent pathogen in people with CF (pwCF) or bronchiectasis. Their clinical role and management remain unclear, and their isolation is a challenge. In this paper, we describe four cases of Nocardia detection, in two pwCF and two patients with non-CF bronchiectasis or primary ciliary dyskinesia (PCD). <b>Methods:</b> We conducted a multicenter retrospective study, involving pwCF and non-CF people with bronchiectasis who presented with a <i>Nocardia</i> detection and were followed at three CF Italian centers (Florence, Verona, and Cerignola). <b>Results:</b><i>Nocardia</i> detection was associated with clinical and radiological respiratory exacerbation and decline in lung function. In one CF patient, <i>Nocardia</i> was not detected in sputum cultures after starting Elexacaftor-Tezacaftor-Ivacaftor therapy. <b>Conclusions:</b> Managing <i>Nocardia</i> detection in patients with underlying lung diseases such as CF, PCD, or bronchiectasis presents significant challenges for clinicians.</p>\",\"PeriodicalId\":54246,\"journal\":{\"name\":\"Antibiotics-Basel\",\"volume\":\"14 3\",\"pages\":\"\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-03-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11939271/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antibiotics-Basel\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/antibiotics14030317\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antibiotics-Basel","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/antibiotics14030317","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Nocardia Isolation in People with Cystic Fibrosis and Non-CF Bronchiectasis: A Multicenter Italian Study.
Background:Nocardia species are an emergent pathogen in people with CF (pwCF) or bronchiectasis. Their clinical role and management remain unclear, and their isolation is a challenge. In this paper, we describe four cases of Nocardia detection, in two pwCF and two patients with non-CF bronchiectasis or primary ciliary dyskinesia (PCD). Methods: We conducted a multicenter retrospective study, involving pwCF and non-CF people with bronchiectasis who presented with a Nocardia detection and were followed at three CF Italian centers (Florence, Verona, and Cerignola). Results:Nocardia detection was associated with clinical and radiological respiratory exacerbation and decline in lung function. In one CF patient, Nocardia was not detected in sputum cultures after starting Elexacaftor-Tezacaftor-Ivacaftor therapy. Conclusions: Managing Nocardia detection in patients with underlying lung diseases such as CF, PCD, or bronchiectasis presents significant challenges for clinicians.
Antibiotics-BaselPharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
CiteScore
7.30
自引率
14.60%
发文量
1547
审稿时长
11 weeks
期刊介绍:
Antibiotics (ISSN 2079-6382) is an open access, peer reviewed journal on all aspects of antibiotics. Antibiotics is a multi-disciplinary journal encompassing the general fields of biochemistry, chemistry, genetics, microbiology and pharmacology. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, there is no restriction on the length of papers.